Navigation Links
Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek,
Date:1/19/2010

Using Ocean Tomo’s Proprietary PatentRatings® System World’s Most Inventive Companies Are Ranked Based on Patent Quality, Not Quantity

Chicago, IL (PRWeb) January 19, 2010-- Ocean Tomo, LLC, the Chicago-based Intellectual Capital Merchant Banc® firm, announced the results of a proprietary study performed for Bloomberg BusinessWeek.

The study, which ranks the 25 companies with the Most Valuable Patent Portfolios, was performed using the Ocean Tomo PatentRatings® system. This proprietary web-based platform (U.S. Patent No. 6,556,992) calculated the relative quality of patents issued by the world’s 1,000 largest companies (by revenue). “Ranking companies based on their patent value is critical, as not all patents are created equally,” states Jonathan Barney, PatentRatings® system inventor and Ocean Tomo Managing Director, “Simply counting how many patents a firm holds can lead to a very misleading view.”

The Ocean Tomo PatentRatings® study conducted for Bloomberg BusinessWeek suggests that companies holding high quality patents do indeed shape their respective industries. “Patents are one of the most reliable and critical indicators of a company’s strategic intent,” says James E. Malackowski, President and CEO of Ocean Tomo. “Furthermore, companies holding valuable patents in sufficient quantity are likely to shape industry direction and outperform their peers with respect to equity returns.” Malackowski cites the strong performance of the Ocean Tomo 300® Patent Index (NYSE Euronext: OTPAT) and related Exchange Traded Fund (NYSE Arca: OTP) as support for the firm’s conclusions. "The ultimate value of a patent portfolio is not the rating or even licensing income; both are indirect effects” notes Malackowski. “The ultimate measure of value is the portfolio's effect on earnings and stock price. Our rating system has proven to be a forward looking indication of stock value with proven out-performance over a sustained period of time.”

Top 25 firms selected cumulatively account for about $1.6 Trillion in annual sales and enterprise value of about $2.5 Trillion (median revenue of $53 Billion with a firm value of $46 Billion). The inventions of these firms significantly influence the global economy and their respective industry sectors such as Computers, Wireless, Medical/Pharmaceutical, Industrials, Semiconductors and Consumer Electronics.

By studying the patents issued to a company over the past five years, Ocean Tomo determines how inventive a firm is using its proprietary patent quality measure, the IPQ® score (as provided by www.patentratings.com). The IPQ® score is a numerical measure of patent quality with a median value set at 100. “To use IPQ® scores as a proxy for measuring the inventiveness of a firm, we time adjust (e.g., age, technology obsolescence rates) the data, recognizing that a patent has a finite useful life,” explains Barney. “Although the business community has historically leveraged financial data and market share information to assess relative competitiveness of firms, going forward, it will be critical to identify inventive strength.”    

Ocean Tomo reports that the total Inventiveness Index of a firm signifies inventive prowess of a company as well as its likely ability to have a defensible advantage in the marketplace. Collectively such data demonstrates an indication of true value creation ability.

Methodology for Top 25 Most Inventive Company Selection
The Top 25 Most Inventive Companies were selected from the 1,000 listed companies with the greatest revenue over the most recently reported trailing one year period (9/2008 to 9/2009). These firms were rank ordered based on an analysis of their patent portfolio over the past five years using Ocean Tomo PatentRatings® software to calculate the relative quality of all patents issued by the U.S. Patent and Trademark Office. The system analyzes more than fifty independent and objective factors. Scores are based on identified predictor variables (“metrics”) determined to have statistically significant correlation to the payment of patent maintenance fees (periodic taxes paid to the U.S. Patent Office).

The premise of the rating model is that more valuable, higher-quality patents will be maintained at a higher frequency (have a longer lifespan) than less-valuable patents. Typical metrics include the number, length and type of patent claims, the presence or absence of limiting claim language, the patent prosecution history, the technology classification, the growth rates and filing of new applications in a given technology space, and more than thirty other relevant factors. Ocean Tomo’s patent quality scores are calculated by multiplying statistically-determined coefficients with variables representing each of the relevant metrics, and then by normalizing the resulting values to an appropriate scale.

About Ocean Tomo PatentRatings® Software System
Ocean Tomo PatentRatings® software system is the first proven, market-validated software platform for objectively assessing patent quality, relative valuation, and competitive trends for patents, patent portfolios, companies, and technology sectors. The PatentRatings® system provides customizable data solutions and delivers actionable data to companies, investors, bankers, attorneys and other intellectual property professionals and decision makers. Ocean Tomo PatentRatings® provides an unparalleled understanding of patent quality, technology implications, and strategic insight. Visit PatentRatings (www.PatentRatings.com) for more information about data subscriptions or individual reports.

About Ocean Tomo
Established in 2003, Ocean Tomo, LLC (www.OceanTomo.com), is the leading Intellectual Capital Merchant Banc® firm. The company provides financial products and services related to Intellectual Property expert testimony, research, investments, risk management and transactions. Ocean Tomo assists clients – corporations, law firms, governments and institutional investors – in realizing Intellectual Capital Equity® value broadly defined.

###

Read the full story at http://www.prweb.com/releases/oceantomopatentratings/mostinventivecompanies/prweb3470224.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Panther Expedited Services Unveils New Brand; Services Include Ground, Air, Ocean, & Logistics
2. MIT reels in RNA surprise with microbial ocean catch
3. New Study: Lp(a) Joins LDL as Heart Disease Risk Factor
4. Stroke Therapy with Corkscrew Device Most Beneficial, Study Suggests
5. Study: Era of Rapid Growth in Biomedical Research Over
6. D-Pharm (TASE: DPRM) Announces Enrollment of First Patient in DP-b99 Phase III Efficacy Study, MACSI
7. Institut Paoli Calmettes and Ipsogen Presented a New Study Supporting the Pivotal Role of Tumor Grade in Chemotherapy Prescription at the 32nd Annual San Antonio Breast Cancer Symposium
8. Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans
9. Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain
10. Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimers Disease
11. AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek,
(Date:2/5/2016)... DIEGO , Feb. 5, 2016 On ... region,s trusted information source for community, health and disaster ... Diego) will integrate to enhance care coordination and ... to the services they need and to better connect ... improve care.   San Diego ...
(Date:2/4/2016)... - New FDA action date of July ... action date of July 22, 2016   --> ... 22, 2016   - Lifitegrast has the ... for the treatment of signs and symptoms of dry eye disease ... to be the only product approved in the U.S. in the past decade indicated for ...
(Date:2/4/2016)... SHENZHEN, China , Feb. 4, 2016 ... government, and various medical institutions attended a ceremony in ... provide integrative, personalized cell therapy in 2016. ... the "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" ... Shenzhen Regional Cell Production Center, both subsidiaries of Beike ...
(Date:2/4/2016)... Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... Conference 2016, to be held February 8-9, 2016, at ... 2016 Disruptive Growth & Healthcare Conference, taking place in ... 2016. James Sapirstein , Chief Executive Officer ...
Breaking Biology Technology:
(Date:2/3/2016)... , February 4, 2016 --> ... to SEK 1,351.5 M (105.0), up 1,187% compared with fourth quarter of ... amounted to SEK 517.6 M (loss: 30.0). Earnings per share ... activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% compared with ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... analysis of the bioinformatic market by reviewing the ... computer enabled tools that drive the field forward. ... report to: Identify the challenges and opportunities ... service providers and software solution developers, as well ...
(Date:2/1/2016)... BURNABY, Canada , February 1, 2016 ... new technological advancements to drive global touchfree intuitive gesture ...   --> Rising sales of consumer electronics ... intuitive gesture control market size ... of consumer electronics coupled with new technological advancements to ...
Breaking Biology News(10 mins):